CRO support for ncats in vitro and in vivo toxicology studies

Ended Awarded Last action

Contract number
HHSN271201700015I
Awardee
Awarding agency
Task orders
6 $8,470,822 obligated

Award facts

Opportunity
Combined order value
  • $8,470,822 Current, with exercised options
  • $8,579,937 Potential, with all options
Last date to order 100% complete
IDV ceiling 21% used
$39,804,016.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Non-clinical safety assessment of NES100 to support analgesia indication. POP: 09/18/2020 to 04/17/2021. 75N95020F00002 National Institute on Drug Abuse (NIH) $4,734,236
Non-clinical safety of dipma-AP to support chronic pain indication. POP: 09/17/2020 to 01/16/2021. 75N95020F00003 National Institute on Drug Abuse (NIH) $2,890
Non-clinical safety assessment of JM-4 to support multiple sclerosis and traumatic brain injury indication. 75N95020F00001 National Institute on Drug Abuse (NIH) $460,936
Non-clinical safety assessment of VK4-116 to support human patients afflicted with severe pain disorders. 75N95019F00088 National Institute on Drug Abuse (NIH) $2,634,086
Single i/v, 13-hour infusion, cardiovascular and pulmonary safety pharmacology study of HBN-1 in telemetered… 75N95018F00002 National Institute on Drug Abuse (NIH) $634,385
To award task non-clinical safety assessment of CTI-1601 to support ataxia indication to battelle HHSN27100001 National Institute on Drug Abuse (NIH) $4,288

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $0
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $0
Vendor DUNS or Name Change - Non-Novation 3 $0
Other Administrative Action 2 $0
Funding Only Action 1 -$6,500
Original award $6,500

Subawards

Subcontractor Amount Awarded
Inotiv, Inc. NON-CLINICAL SAFETY ASSESSMENT OF NES100 TO SUPPORT ANALGESIA INDICATION Bone marrow Micronucleus Analysis $50,000
Amplifybio LLC NON-CLINICAL SAFETY ASSESSMENT OF NES100 TO SUPPORT ANALGESIA INDICATION three tox studies $1,542,962
Inotiv, Inc. NON-CLINICAL SAFETY ASSESSMENT OF NES100 TO SUPPORT ANALGESIA INDICATION AMES Assay, Chromosome Aberration, and HERG Concentration $305,495

Quick answers

Who was awarded contract HHSN271201700015I?

HHSN271201700015I was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on April 21, 2017.

How much is contract HHSN271201700015I worth?

Orders under HHSN271201700015I have obligated $8,470,822. Their combined potential value, with all options, is $8,579,937. HHSN271201700015I's own ceiling is $39,804,016.

How many orders have been placed under contract HHSN271201700015I?

6 orders have been placed under HHSN271201700015I, the latest on September 18, 2020.

Which agency awarded contract HHSN271201700015I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700015I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201700015I?

HHSN271201700015I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201700015I part of a contract vehicle?

Yes. HHSN271201700015I is part of CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.

Was contract HHSN271201700015I competed?

The extent of competition for HHSN271201700015I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login